A critical discovery in cancer study is occurring with the use of mini-antibodies to reactivate mutated p53. This essential tumor protector protein is frequently disabled in various kinds of malignancies, resulting https://madbookmarks.com/story21989162/nanobodies-revive-the-p53-protein-a-potential-hope-for-tumor-therapy